scispace - formally typeset
Open AccessJournal Article

[What is a cost-benefit analysis?].

Thomas MüLLER-BOHN
- 01 Oct 2004 - 
- Vol. 27, Iss: 10, pp 328-330
Reads0
Chats0
About
This article is published in Medizinische Monatsschrift für Pharmazeuten.The article was published on 2004-10-01 and is currently open access. It has received 844 citations till now. The article focuses on the topics: Total absorption costing & Relevant cost.

read more

Citations
More filters
Journal ArticleDOI

Cost-effectiveness of recombinant follicle-stimulating hormone (FSH) versus human FSH in intrauterine insemination cycles: A statistical model-derived analysis

TL;DR: This study represents the first statistical model developed with a computer-generated clinical simulation with the intent to elaborate a pharmacoeconomic comparison between rFSH and hFSH in ovarian stimulation for IUI cycles and demonstrated that hF SH is more cost-effective than rF SH.
Journal ArticleDOI

The “Montias case,” 1964 ☆: Excerpt from János Kornai's book By Force of Thought: Irregular Memoirs of an Intellectual Journey

TL;DR: Janos Kornai, a distinguished Hungarian economist, began his adult life as an ardent believer in socialism and then became a critic of the communist political and economic system as mentioned in this paper.
Journal ArticleDOI

Intra-amniotic Dye Alternatives for the Diagnosis of Preterm Prelabor Rupture of Membranes

TL;DR: Of the dye options available, fluorescein is a readily available commercial option that has the best evidence supporting use and safety for these indications and is the most likely to be used in pregnancy.
Journal ArticleDOI

Validating and Assessing the Sensitivity of the Health Assessment Questionnaire-Disability Index-derived Short Form-6D in Patients with Early Aggressive Rheumatoid Arthritis

TL;DR: The data support the validity and responsiveness of the HAQ-DI derived SF-6D score in an early RA cohort and clinical trials lacking preference-based measures.
Journal ArticleDOI

Cannabis policies in Canada: How will we know which is best?

TL;DR: A framework for a cost benefit analysis (CBA) is developed outlining in some detail the data that is needed to undertake a credible economic evaluation of cannabis policies and provides a framework for subsequent cost benefit analyses which can quantify said harms and benefits.
References
More filters
Journal ArticleDOI

Plant Ecological Strategies: Some Leading Dimensions of Variation Between Species

TL;DR: The leaf mass per area–leaf lifespan (LMA-LL) dimension expresses slow turnover of plant parts, long nutrient residence times, and slow response to favorable growth conditions.
Journal ArticleDOI

Can Electronic Medical Record Systems Transform Health Care? Potential Health Benefits, Savings, And Costs

TL;DR: In this paper, the potential health and financial benefits of health information technology (HIT) are examined and the potential savings and costs of widespread adoption of electronic medical record (EMR) systems, models important health and safety benefits, and concludes that effective EMR implementation and networking could eventually save more than $81 billion annually.
Book Chapter

Assessment of adaptation practices, options, constraints and capacity

TL;DR: Enright et al. as discussed by the authors presented the Enright-Fankhauser-Gabel-Nantel-Klein model, which is based on the work of the authors of this paper.
Journal ArticleDOI

Sustainable Tourism: An Overview of the Concept and its Position in Relation to Conceptualisations of Tourism

TL;DR: In this article, the authors argue that sustainable tourism has traditionally given more focus to aspects related to the environment and economic development, and that more focus should be given to community involvement.